Difficulty: Medium
Average Score: 82%
Practice
A nurse at a long-term care facility is amending the care plan of a resident who has just been diagnosed with essential thrombocythemia (ET). The nurse should anticipate the administration of what medication?
Correct answer
C
Rationale
In this scenario, the correct medication for a resident diagnosed with essential thrombocythemia (ET) is hydroxyurea (Option C). Hydroxyurea is an antimetabolite that works by reducing the production of blood cells, particularly platelets, which is crucial in managing ET to prevent clotting complications.
Option A, Dalteparin, is a low molecular weight heparin used for anticoagulation, which is not the primary treatment for ET. Option B, Allopurinol, is used to reduce uric acid levels in conditions like gout, not for ET. Option D, Hydrochlorothiazide, is a diuretic used to manage hypertension and edema, not indicated for ET.
Educationally, understanding the rationale behind choosing the correct medication is vital for nurses caring for patients with hematologic disorders. Knowing the mechanism of action and therapeutic use of hydroxyurea in ET helps nurses provide safe and effective care, monitor for side effects, and educate patients on treatment goals. This knowledge enhances the nurse's ability to advocate for appropriate treatment and collaborate effectively with the healthcare team to optimize patient outcomes in oncology and hematology settings.
Option A, Dalteparin, is a low molecular weight heparin used for anticoagulation, which is not the primary treatment for ET. Option B, Allopurinol, is used to reduce uric acid levels in conditions like gout, not for ET. Option D, Hydrochlorothiazide, is a diuretic used to manage hypertension and edema, not indicated for ET.
Educationally, understanding the rationale behind choosing the correct medication is vital for nurses caring for patients with hematologic disorders. Knowing the mechanism of action and therapeutic use of hydroxyurea in ET helps nurses provide safe and effective care, monitor for side effects, and educate patients on treatment goals. This knowledge enhances the nurse's ability to advocate for appropriate treatment and collaborate effectively with the healthcare team to optimize patient outcomes in oncology and hematology settings.